Deferred versus Expedited Aortic Valve Replacement in Patients with Symptomatic Severe Aortic Stenosis During the SARS-CoV-2 Pandemic (AS DEFER): A Research Letter.
作者信息
Lanz Jonas, Ryffel Christoph, Corpataux Noé, Reusser Nicole, Okuno Taishi, Langhammer Bettina, Reineke David, Praz Fabien, Stortecky Stefan, Windecker Stephan, Pilgrim Thomas
机构信息
Department of Cardiology, Inselspital, Bern University Hospital, University of Bern, CH.
Department of Cardiovascular Surgery, Inselspital, Bern University Hospital, University of Bern, CH.
出版信息
Glob Heart. 2021 Apr 30;16(1):32. doi: 10.5334/gh.989.
Abstract
摘要
相似文献
1
Deferred versus Expedited Aortic Valve Replacement in Patients with Symptomatic Severe Aortic Stenosis During the SARS-CoV-2 Pandemic (AS DEFER): A Research Letter.新冠疫情期间有症状重度主动脉瓣狭窄患者延迟与加速主动脉瓣置换术（AS DEFER）：一封研究信
Glob Heart. 2021 Apr 30;16(1):32. doi: 10.5334/gh.989.
2
Transcatheter management of severe aortic stenosis during the COVID-19 pandemic.COVID-19大流行期间严重主动脉瓣狭窄的经导管治疗
Heart. 2020 Aug;106(15):1183-1190. doi: 10.1136/heartjnl-2020-317221. Epub 2020 Jun 10.
3
Mortality, Stroke, and Hospitalization Associated With Deferred vs Expedited Aortic Valve Replacement in Patients Referred for Symptomatic Severe Aortic Stenosis During the COVID-19 Pandemic.在 COVID-19 大流行期间，因症状性重度主动脉瓣狭窄而接受主动脉瓣置换术的患者中，与延迟 vs 紧急主动脉瓣置换相关的死亡率、卒中和住院情况。
JAMA Netw Open. 2020 Sep 1;3(9):e2020402. doi: 10.1001/jamanetworkopen.2020.20402.
4
Management of elective aortic valve replacement over the long term in the era of COVID-19.COVID-19时代择期主动脉瓣置换术的长期管理
Eur J Cardiothorac Surg. 2020 Jun 1;57(6):1029-1031. doi: 10.1093/ejcts/ezaa152.
5
Severe aortic stenosis patient risk during the COVID-19 pandemic.新冠疫情期间重度主动脉瓣狭窄患者的风险
Open Heart. 2020 Sep;7(2). doi: 10.1136/openhrt-2020-001355.
6
Characteristics and Outcomes of Patients Deferred for Transcatheter Aortic Valve Replacement Because of COVID-19.因 COVID-19 而延迟行经导管主动脉瓣置换术患者的特征和结局。
JAMA Netw Open. 2020 Sep 1;3(9):e2019801. doi: 10.1001/jamanetworkopen.2020.19801.
7
Reply: Transcatheter Aortic Valve Implantation During COVID-19 Pandemic: The Device Also Matters.回复：COVID-19大流行期间的经导管主动脉瓣植入术：器械也很重要。
Cardiovasc Revasc Med. 2021 May;26:68. doi: 10.1016/j.carrev.2020.09.009. Epub 2020 Sep 5.
8
Aortic stenosis in the time of COVID-19: Development and outcomes of a rapid turnaround TAVI service.COVID-19 时期的主动脉瓣狭窄：快速周转经导管主动脉瓣置换术服务的发展和结果。
Catheter Cardiovasc Interv. 2021 Sep;98(3):E478-E482. doi: 10.1002/ccd.29550. Epub 2021 Feb 10.
9
Cost-effectiveness of the Edwards SAPIEN transcatheter heart valve compared with standard management and surgical aortic valve replacement in patients with severe symptomatic aortic stenosis: a Canadian perspective.经导管主动脉瓣置换术治疗严重症状性主动脉瓣狭窄患者的成本效益：从加拿大角度评估爱德华兹 SAPIEN 经导管心脏瓣膜与标准治疗及外科主动脉瓣置换术的比较。
J Thorac Cardiovasc Surg. 2013 Jul;146(1):52-60.e3. doi: 10.1016/j.jtcvs.2012.06.018. Epub 2012 Jul 11.
10
A cost-utility analysis of transcatheter versus surgical aortic valve replacement for the treatment of aortic stenosis in the population with intermediate surgical risk.经导管主动脉瓣置换术与外科主动脉瓣置换术治疗中危外科手术风险主动脉瓣狭窄的成本-效用分析。
J Thorac Cardiovasc Surg. 2018 May;155(5):1978-1988.e1. doi: 10.1016/j.jtcvs.2017.11.112. Epub 2018 Feb 2.
本文引用的文献
1
Increasing Wait-Time Mortality for Severe Aortic Stenosis: A Population-Level Study of the Transition in Practice From Surgical Aortic Valve Replacement to Transcatheter Aortic Valve Replacement.严重主动脉瓣狭窄患者等待时间导致的死亡率增加：一项关于从外科主动脉瓣置换术到经导管主动脉瓣置换术实践转变的人群水平研究。
Circ Cardiovasc Interv. 2020 Nov;13(11):e009297. doi: 10.1161/CIRCINTERVENTIONS.120.009297. Epub 2020 Nov 10.
2
Mortality, Stroke, and Hospitalization Associated With Deferred vs Expedited Aortic Valve Replacement in Patients Referred for Symptomatic Severe Aortic Stenosis During the COVID-19 Pandemic.在 COVID-19 大流行期间，因症状性重度主动脉瓣狭窄而接受主动脉瓣置换术的患者中，与延迟 vs 紧急主动脉瓣置换相关的死亡率、卒中和住院情况。
JAMA Netw Open. 2020 Sep 1;3(9):e2020402. doi: 10.1001/jamanetworkopen.2020.20402.
Zotero 插件